Mobile

This clinical study evaluates the efficacy and safety of regorafenib in patients with advanced liver cancer who have progressed on sorafenib treatment

Update Il y a 4 ans
Reference: EUCTR2012-003649-14

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The objective of this study is to evaluate efficacy and safety of regorafenib in patients with HCC who have progressed after sorafenib

Inclusion criteria

  • Hepatocellular carcinoma (HCC)

Links